TrialClinical cancer research : an official journal of the American Association for Cancer Research2022

Circulating Immune Cell and Outcome Analysis from the Phase II Study of PD-L1 Blockade with Durvalumab for Newly Diagnosed and Recurrent Glioblastoma.

Lakshmi Nayak et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.